Thomas Appio - 27 Feb 2026 Form 4 Insider Report for Bausch Health Companies Inc. (BHC)

Reporting relationship: Chief Executive Officer, Director
Issuer ticker: BHC
Reported as of: 27 Feb 2026
Net transaction value: -$7,761,065
SEC form: 4
Accepted by SEC: 03 Mar 2026, 17:41:01 UTC
Prior SEC filing: 27 Feb 2026
Next SEC filing: 14 Aug 2026
Source filing: View source filing
Reporting owner signature: /s/ Brianna M. Dorsi attorney-in-fact

Key filing fact

Thomas Appio filed Form 4 for Bausch Health Companies Inc. (BHC) on 03 Mar 2026.

Key facts

This page summarizes Thomas Appio's Form 4 filing for Bausch Health Companies Inc. (BHC).
3 reported transactions and 0 derivative rows are listed below.
Accepted by SEC: 03 Mar 2026, 17:41.

Change

Previous filing in this sequence was filed on 27 Feb 2026.
Current net transaction value: -$7,761,065.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001683323 Primary reporting owner

APPIO THOMAS

Relationship: Chief Executive Officer, Director
Address: 400 SOMERSET CORPORATE BOULEVARD, BRIDGEWATER
Signature: /s/ Brianna M. Dorsi attorney-in-fact
Signature date: 03 Mar 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

BHC transaction

Common Shares, No Par Value

Tax liability

Transaction value: $492,741
Shares: -83,093
Change %: -2.3%
Price: $5.93
Shares after: 3,536,941
Date: 27 Feb 2026
Ownership: Direct
Footnotes: F1

BHC transaction

Common Shares, No Par Value

Tax liability

Transaction value: $498,045
Shares: -83,705
Change %: -2.4%
Price: $5.95
Shares after: 3,453,236
Date: 02 Mar 2026
Ownership: Direct
Footnotes: F2

BHC transaction

Common Shares, No Par Value

Other

Transaction value: $6,770,279
Shares: -1,137,862
Change %: -33%
Price: $5.95
Shares after: 2,315,374
Date: 02 Mar 2026
Ownership: Direct
Footnotes: F3

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

This number represents common shares, no par value, of the Issuer withheld to satisfy the tax withholding obligations due upon vesting of Restricted Share Units.

Footnote F2

This number represents common shares, no par value, of the Issuer withheld to satisfy the tax withholding obligations due upon vesting of Restricted Share Units.

Footnote F3

Reflects the settlement in cash of 1,137,862 performance share unit awards originally granted to the Reporting Person under the Bausch Health Companies, Inc. 2014 Omnibus Incentive Plan on March 2, 2023, which, as previously reported on February 11, 2026, were earned, on February 9, 2026, upon certification by the Talent and Compensation Committee (the "Committee") of the Board of Directors of the Issuer of the level of achievement of the applicable performance metrics, but remained subject to service-based vesting. As disclosed in the Issuer's Current Report on Form 8-K filed with the Securities and Exchange Commission on March 2, 2026, the Committee subsequently took action to provide for the payment of such earned performance share unit awards in cash rather than Issuer common stock upon vesting. The settlement in cash is exempt under Rule 16b-3(e).